Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 968 12.24 (1.28%) Market Cap: 106.66 Bil Enterprise Value: 97.49 Bil PE Ratio: 28.60 PB Ratio: 3.95 GF Score: 94/100

Regeneron Pharmaceuticals Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript

Jun 23, 2020 / 02:00PM GMT
Release Date Price: $628.76 (+0.04%)
Matthew W. Luchini
BMO Capital Markets Equity Research - Analyst

All right. Good morning, everyone. My name is Matthew Luchini, one of the biotech analysts here at BMO. Welcome to the Virtual Prescriptions for Success Conference, and to my portion of the fireside chat. It's my pleasure to welcome for my first fireside chat of today, Regeneron, and in particular, today, we have Justin Holko, Vice President of Investor Relations. Justin, it's a pleasure to have you here. Welcome. Let me go ahead and open it up to you for a few opening remarks, and we can go ahead and get started.

Justin Holko
Regeneron Pharmaceuticals, Inc. - VP of IR

Great. Thank you, Matthew, and it's a pleasure to be joining you today. I think this is the first time we've joined your conference. And if not the first time, it's been quite a while. So thank you for the invitation. Just a reminder to everybody, we will be making some statements today that will be forward-looking in nature. For a full reading of all the risks and uncertainties associated with the business that could impact those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot